Background: The success of rotator cuff repair is primarily dependent on tendon-bone healing. Failure is common because weak scar tissue replaces the native enthesis, rendering it prone to reruptures. A demineralized bone matrix (DBM) consists of a network of collagen fibers that provide a sustained release of growth factors such as bone morphogenetic proteins. Previous studies have demonstrated that it can regenerate a fibrocartilaginous enthesis.
vivo examinations of the behavior of MSCs in enthesis regeneration have reported the absence of a fibrocartilaginous interface, citing the lack of signaling as a reason for the transplanted cells not differentiating and leading to a poor outcome. 17 To enhance their effect, researchers have engineered stem cells in vitro to express specific proteins. 18, 19 In doing so, the addition of these cells has increased fibrocartilage production and improved the strength of the repair. 18 A demineralized bone matrix (DBM) consists of a network of collagen fibers that provide a sustained release of growth factors such as bone morphogenetic proteins (BMPs). 33, 40 Wurgler-Hauri et al 51 demonstrated that a slow release of growth factors is required for tendon-bone healing, and there is evidence to indicate that BMPs are important proponents of a naturally graduated, mechanically favorable enthesis. 3, 28, 32 The differentiation of MSCs can be directed by the introduction of BMPs, a property that may be utilized to increase the production of mineralized fibrocartilage at the healing enthesis. 12, 16, 26, 39 A DBM has been shown to regenerate a strong enthesis with mineralized fibrocartilage in both acute and chronic tear models of tendon-bone healing. 40, 41 Similar results have additionally been demonstrated in a large animal model of severe tendon retraction. 42 Because the ultimate strength of the tendon-bone interface is dependent on bony ingrowth and the development of fibrocartilage, we speculate that the addition of MSCs into a DBM-based repair construct will produce an enthesis resembling the native insertion site with a natural gradation between tendon, demineralized fibrocartilage, mineralized fibrocartilage, and bone.
The purpose of this study was to determine if a DBM enhanced with MSCs could improve tendon-bone healing when applied to a degenerative rotator cuff tear model. We compared a DBM with a commercially available human dermal matrix graft, which has been used clinically for enthesis repair (GraftJacket; Wright Medical Technology). The hypothesis was that in a rat model of chronic rotator cuff tears, the addition of a DBM and MSCs to the healing enthesis would result in a higher bone mineral density at the tendon insertion, and that this combination would lead to regeneration of a morphologically superior enthesis characterized by greater fibrocartilage formation and improved collagen fiber organization in a rat model of a chronic rotator cuff tear when compared with an acellular human dermal matrix.
Furthermore, to determine whether MSCs could enhance the structure of the healing enthesis compared with repairs without MSCs, the results of this experiment were compared with a previously published study that utilized the same animal model and scaffolds. 41 It was hypothesized that the addition of MSCs would yield a morphologically superior interface and increased bone mineral density at the tendon insertion.
METHODS

Study Design
All animal work was conducted in accordance with a project license protocol accepted under the UK Animals (Scientific Procedures) Act 1986. Eighteen female Wistar rats underwent unilateral detachment of the supraspinatus tendon, and an additional 1 animal from the same genus was used to obtain bone marrow-derived MSCs. Previously published data were used to calculate the number of animals (n = 6) required to generate a power of 0.8 with significance at the 0.05 level. 40 It has been demonstrated that detachment of the supraspinatus tendon in rats results in morphological changes similar to those that occur in the clinical setting. 5 After 3 weeks, tendon repair was carried out in animals randomized into 3 groups: group 1 received augmentation of the repair with a cortical allogenic DBM (n = 6); group 2 received augmentation with a nonmeshed, ultrathick, acellular human dermal matrix (n = 6) (mean, 1.4-mm thickness; GraftJacket); and group 3 underwent tendon-bone repair without a scaffold (n = 6). All animals received 1 3 10 6 MSCs in a fibrin sealant (Tisseel; Baxter), and 1 animal from each study group received MSCs labeled with quantum dots (QDs) (Qtracker 655; Invitrogen) for cell tracking. To minimize the number of animals used, as per UK Home Office regulations, fibrin glue devoid of MSCs was not used as an experimental group, as it has previously been shown not to enhance healing of the enthesis. 17, 37, 52 One surgeon (T.T.) carried out all procedures using a standard technique. Animals were allowed to mobilize freely after surgery. Specimens were retrieved at 6 weeks postoperatively for histological analysis and peripheral quantitative computed tomography (pqCT) to evaluate bone mineral density at the reattachment footprint of the tendon, reversal of degenerative changes within the tendon, and histological remodeling of the implanted augmentation material.
Acellular Human Dermal Matrix Preparation
GraftJacket is obtained from donated human cadaveric dermal tissue processed to remove its cellular components while retaining its extracellular matrix. Its acellularity has the advantage of not causing a host inflammatory reaction, and it has been safely used in rats to enhance healing of a large acute rotator cuff tear. 21 Samples of the dermal matrix were rehydrated at the time of surgery in normal saline for 30 minutes before use.
DBM Manufacture
A DBM derived from cortical bone was manufactured according to Urist's 47 protocol, with modifications. The tibiae of skeletally mature female Wistar rats were harvested immediately after euthanasia; all soft tissues and the periosteum were stripped from the bone surface. Bones measuring approximately 30 mm in length by 3 mm in width were demineralized in 0.6 N HCL at room temperature ( Figure 1 ). Demineralization was confirmed by taking radiographs (300 seconds, 30 kV; Faxitron). This was followed by washing in phosphate-buffered saline until the pH was 7.4 6 0.1. Samples were stored at -20°C for 2 hours and transferred to a lyophilizer (Girovac) for 3 days ( Figure  2 ). Specimens were then sealed in individual plastic bags, sterilized by gamma irradiation at a dose of 25 kGy (Isotron), and stored at -20°C. Samples were rehydrated at the time of surgery in sterile saline solution for 30 minutes before use.
Bone Marrow-Derived MSC Harvest and Culture One 6-month-old female Wistar rat was euthanized by carbon dioxide inhalation, and both femurs were harvested under sterile conditions. MSCs were harvested by lavaging the intramedullary canals with Dulbecco's modified Eagle's medium (DMEM; Invitrogen) containing 10% fetal calf serum (HyClone; GE Healthcare) and 1% penicillin/streptomycin solution (Thermo Fisher Scientific) to obtain a bone marrow aspirate, which was plated onto T75 culture flasks. Cells were cultured at 37°C in a 5% carbon dioxide incubator. After 5 days, the contents of the flask were removed and washed with media, leaving the MSCs that adhered to the bottom of the flask. Afterwards, media were changed twice a week for 14 days. Once confluent, the MSCs were detached with trypsin and serially subcultured. Third passage cells were used for implantation. Previous studies have shown that this protocol is a reliable method of obtaining MSCs and that their pluripotency is maintained up to the third passage. 1, 17, 18, 34, 46 No immunogenic reaction was anticipated with stem cell implantation because the rats from which cells were harvested were the same strain as those receiving them.
Surgical Technique
Two surgical procedures were performed on each animal: full-thickness supraspinatus tendon detachment and complete tendon reattachment. Anesthesia was induced and maintained using 2% isoflurane mixed with pure oxygen via a facemask for both procedures. The right shoulder was operated on in all cases. A 1.5-cm skin incision was made directly over the anterolateral border of the acromion. The deltoid was detached from the acromion and split caudally for 0.5 cm to identify the supraspinatus tendon. The supraspinatus tendon was completely detached from its bony insertion on the humeral head, marked with a 5-0 Prolene suture (Ethicon) at the musculotendinous junction, and allowed to retract medially. The deltoid muscle, superficial fascia, and skin were closed with a 5-0 Vicryl suture (Ethicon). Animals were allowed unrestricted cage activity and received analgesia (subcutaneous buprenorphine) every 12 hours for 3 days. The second surgical procedure to reattach the tendon was undertaken 3 weeks after the first procedure. Before making the skin incision, the DBM or dermal matrix was rehydrated for 30 minutes in sterile normal saline at the operating table.
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A 2-cm skin incision was made in line with the supraspinatus muscle belly, ending anterior to the lateral end of the clavicle. This approach was perpendicular to the incision used for tendon detachment to make use of a virgin anatomic plane devoid of scar tissue. The muscle belly of the supraspinatus was identified and followed distally to reveal the tendon stump with the suture marker in the musculotendinous junction. Scar tissue between the tendon stump and its insertion was excised, and the tendon was grasped with a double-armed 5-0 Prolene suture using a modified Mason-Allen technique. 44 Despite traction on the tendon stump, it could not be directly brought back to the humeral head in any of the cases. The bare tendon-bone insertion footprint was decorticated using a No. 11 surgical blade until bleeding was seen. A custom-made dental drill was used to drill a 1-mm hole from the neck of the humerus to the bony insertion of the detached supraspinatus.
MSCs were incorporated into the repair construct using a fibrin sealant (Tisseel) that contained 2 parts: a vaporheated Tisseel powder dissolved in aprotinin solution and a vapor-heated thrombin powder dissolved in calcium chloride solution. One milliliter of the Tisseel solution contained 100 to 130 mg of total protein, of which 75 to 115 mg was fibrinogen. One milliliter of thrombin solution contained 45 to 55 mg of total protein, of which 500 IU 2 was thrombin. 24 Preoperatively, MSCs were implanted into the thrombin component in vitro at a concentration of 1 3 10 6 cells/100 mL and mixed with the Tisseel solution. The fibrin glue was injected into a custom-made, squareshaped stainless steel mold measuring 1 cm by 1 cm containing DMEM, which provided nutrition to the cells up to the point at which they were implanted ( Figure 3 ).
Each limb of the suture was passed through the scaffold to secure it in position. One suture limb was passed through the hole in the prepared tendon stump, and the other suture limb was passed through the hole on the neck of the humerus. The supraspinatus tendon-scaffold complex was attached to the insertion site, with the graft in contact with both the tendon stump proximally and decorticated bone surface distally. In the control group, the sutures were inserted directly into the drill holes, leaving a 5-mm gap between the tendon and bone in all cases.
Before the graft material (cortical DBM or dermal matrix) was secured during tendon reattachment surgery, the sheet of fibrin glue containing MSCs was placed on the decorticated humeral head while lying in contact with the proximal tendon stump (Figure 4 ). All grafts used to augment healing measured approximately 1.5 cm in length and 3 to 5 mm in width.
In the group in which MSCs were used in isolation, the fibrin glue bridged the gap between the retracted supraspinatus-musculotendinous unit and its bony insertion. The repair construct resembled a laminated structure: superficial layer (cortical DBM/dermal matrix), central layer (fibrin glue with MSCs), and deep layer (humeral head with tendon footprint) ( Figure 5 ).
Layered wound closure was undertaken in a similar manner to the first surgical procedure, and the animals were permitted unrestricted cage activity. Postoperative analgesia (intramuscular buprenorphine 0.6 mg) was given every 12 hours for 3 days.
MSC Tracking
QDs are semiconductor nanoparticles that are phagocytosed or taken up by pinocytosis into cells and distributed within cytoplasmic vesicles, causing the cells to intensely fluoresce. 31 MSCs were able to be tracked using this method. Properties that make QDs suitable for cell tracking include their compatibility with MSCs without affecting proliferation and differentiation and their resistance to chemical and metabolic degradation. 2, 8, 10, 13, 22, 31 In this study, 3 animals (1 from each experimental group) received MSCs labeled with Qtracker 655. QDs were applied to cells at a concentration of 300,000 particle units/1 3 10 6 MSCs. On the morning of surgery, transduced MSCs were suspended in the fibrin sealant, stored in plain DMEM, and implanted at the repair site as described above.
Histological Assessment
At euthanasia, the right shoulder was dissected, and a specimen comprising the humerus with its attached supraspinatusmusculotendinous unit was removed. Each sample was fixed in 10% formal saline and underwent decalcification in EDTA, ascending graded alcohol dehydration, defatting in chloroform, and embedding in paraffin. Using a microtome (Model 1130; Reichert-Jung), multiple 4 mm-thick slides were cut in the coronal plane through the humerus, enthesis, and supraspinatus-musculotendinous unit before staining with hematoxylin and eosin.
Two blinded observers evaluated all sections using a BH-2 light microscope (Olympus). Tendon degeneration was assessed according to a modified Movin scale that was initially conceived to define microstructural features of Achilles tendinopathy. 30 It has subsequently been used as a semiquantitative scoring system to assess tendon degeneration and includes the following variables: (1) fiber structure, (2) fiber arrangement, (3) rounding of nuclei, (4) regional variations in cellularity, (5) increased vascularity, and (6) hyalinization. 4 A 4-point scoring system was used: 0 = normal appearance, 1 = slightly abnormal appearance, 2 = moderately abnormal appearance, and 3 = markedly abnormal appearance. 27 Based on this, the total score for any given slide could range from 0 (normal tendon) to 18 (greatest level of degeneration).
Maturation of the enthesis was assessed according to the scoring system developed by Ide et al 21 that was initially used to characterize the histological features of the tendon-bone interface of rats in which supraspinatus fixation was achieved using a dermal matrix graft. It is a semiquantitative scoring system ranging from 1 to 4 (1 being a poorly defined enthesis and 4 being a well-defined enthesis): 1 = the insertion had continuity without fibrous tissue or bone ingrowth; 2 = the insertion had continuity with fibrous tissue ingrowth but no fibrocartilage cells; 3 = the insertion had continuity with fibrous tissue ingrowth and fibrocartilage cells but no tidemark; and 4 = the insertion had continuity with fibrous tissue ingrowth, fibrocartilage cells, and a tidemark.
The presence of red fluorescence under microscopy was used to confirm the position and distribution of the MSCs containing QDs utilizing a fluorescent microscope (Zeiss).
Peripheral Quantitative Computed Tomography
Changes in bone mineral density at the humeral head were assessed using pqCT. One-millimeter slices were obtained through the humeral head and supraspinatusmusculotendinous unit using an XCT 2000 bone scanner with software version 6.20 (Stratec Medizintechnik). Controls were obtained from the contralateral (nonoperated) shoulder in 6 animals subjected to the same rehabilitation conditions as the study groups.
Statistical Analysis
Nonparametric statistical methods were used for all analyses because of the nonnormality of the data in the groups being compared. Numerical data were inputted into SPSS software version 23 (IBM). Mann-Whitney U tests were used to compare data between the groups. Results were considered significant at the P \ .05 level. To determine whether there was any benefit in using MSCs, the data from this study were compared with those from a previously published one that evaluated the effect of a DBM and dermal matrix on enthesis healing in the same chronic rotator cuff tear model without the addition of MSCs. 41 
RESULTS
All animals survived the duration of the study, and none had postoperative infections. Limping was noted for the first 3 to 5 postoperative days, but a normal gait pattern returned afterwards.
MSC Tracking
QDs were observed using fluorescent microscopy in all specimens where they were implanted, suggesting that the MSCs remained at the tendon-bone interface ( Figure 6 ).
Macroscopic Findings
At the time of euthanasia, there was continuity between the repaired tendon and the bone in all groups. There were no infections, and none of the repairs had failed as illustrated by the intact sutures. Remodeling of the graft material occurred to a greater extent in the DBM group, whereby the scaffold could not be discerned from other tissue types in the regenerated tendon-bone interface. In contrast, the dermal matrix group was clearly visible at necropsy. MSC-only specimens demonstrated complete closure of the enthesis.
Quantitative Histology
Supraspinatus Muscle-Scaffold Interface. Both scaffolds had remodeled completely and were characterized by a well-cellularized interface, similar to controls only repaired with MSCs ( Figure 7) . Enthesis Maturation Score. No significant differences were observed in the enthesis maturation scores between the experimental groups ( Figure 8) . The DBM had remodeled to a greater extent than the dermal matrix, although not completely in all specimens. The median enthesis maturation score was 3.00 (95% CI, 2.47-3.70) in the MSC group, 3.00 (95% CI, 3.00-3.00) in the DBM (Figure 9 ). No significant intergroup differences were identified.
Fiber Arrangement. All groups exhibited a loss of the parallel arrangement observed in an intact tendon-bone interface. The median score was 1.00 (95% CI, 0.52-1.31) in the MSC group, 1.00 (95% CI, 0.81-1.69) in the DBM 1 MSC group, and 2.00 (95% CI, 1.70-2.13) in the dermal matrix 1 MSC group. Fiber arrangement was significantly more abnormal in the dermal matrix group than in the DBM group (P = .014) and MSC group (P = .003). No other significant intergroup differences were identified.
Tenocyte Nuclei. Rounding of nuclei (indicating persistent degeneration) was identified in all groups after tendon reattachment. The median score was 1.00 (95% CI, 0.74-1.60) in the MSC group, 1.50 (95% CI, 0.48-2.19) in the DBM 1 MSC group, and 1.00 (95% CI, 0.79-1.88) in the dermal matrix 1 MSC group. No significant intergroup differences were identified.
Cellularity. Specimens were evaluated for an increase in cellularity, indicating persistent degeneration. The median score was 1.00 (95% CI, 0.56-1.10) in the MSC group, 1.50 (95% CI, 0.72-2.11) in the DBM 1 MSC group, and 1.25 (95% CI, 0.90-1.93) in the dermal matrix 1 MSC group. Cellularity was significantly less (indicating less noticeable degeneration) in the MSC group than in the dermal matrix group (P = .031). No other significant intergroup differences were identified.
Vascularity. Specimens were evaluated for an increase in vascularity, indicating persistent degeneration. 27 The median score was 0.00 (95% CI, -0. 13 Hyalinization. Hyalinization was not observed in any of the specimens.
Peripheral Quantitative Computed Tomography
Total Bone Mineral Density. Control specimens comprised the contralateral shoulder of animals that had undergone unilateral tendon detachment 3 weeks earlier. In this group (n = 6), the median total bone mineral density at the supraspinatus tendon-bone insertion was 793.25 mg/cm 3 (95% CI, 754. 24-844.70 ). This significantly decreased 6 weeks after repair with a dermal matrix 1 MSCs and repair with MSCs alone to a median of 717.25 mg/cm 3 (95% CI, 582.54-782.39; P = .010) and 719.65 mg/cm 3 (95% CI, 666.80-765.27; P = .010), respectively. In repairs with a DBM 1 MSCs, the median total bone mineral density was 701.20 mg/cm 3 (95% CI, 621.27-794.73). This was not significantly different from controls (P = .055) (Figure 10 ). 
Comparison of Histology: MSCs vs No MSCs
Enthesis Maturation Score. Repairs with MSCs alone and a DBM 1 MSCs resulted in a significantly more mature enthesis than repairs augmented with a dermal matrix alone (P = .044 and .007, respectively). There were no significant differences between the other experimental groups (Figure 11) .
Modified Movin Score. Repair with MSCs alone resulted in a significantly less degenerative tendon than repair augmented with a dermal matrix and nonaugmented controls (P = .004 and .008, respectively). Furthermore, the addition of MSCs to a dermal matrix produced a tendon that was significantly less degenerative (P = .025). There were no significant differences between the other experimental groups (Figure 12 ).
Peripheral Quantitative Computed Tomography. No significant increase in bone mineral density was conferred by the addition of MSCs to the healing interface ( Figure 13 ).
DISCUSSION
In this study, we hypothesized that compared with MSCs alone, a DBM 1 MSCs would regenerate a morphologically superior enthesis characterized by greater fibrocartilage formation and improved collagen fiber organization in a rat model of a chronic rotator cuff tear. We further hypothesized that a DBM would result in a higher bone mineral density at the insertion site. These hypotheses are only partially supported by the results.
Using a rat model of a chronic rotator cuff tear, tendons were reattached to their bony insertion with a DBM 1 MSCs, a dermal matrix 1 MSCs, and MSCs alone (controls) and analyzed after 6 weeks. MSCs were confined to the healing enthesis, as illustrated by the presence of QDs on fluorescent microscopy. All groups demonstrated closure of the tendon-bone gap with a fibrocartilaginous enthesis, but the degenerative process could not be reversed (as illustrated by a persistently high modified Movin score). Although there were no significant differences in the enthesis maturation and modified Movin scores, repair augmented with a dermal matrix 1 MSCs exhibited a disorganized enthesis, abnormal collagen fiber arrangement, and greater cellularity (indicating persistent degeneration) compared with other MSC groups. In addition to these histological parameters, the bone mineral density at the enthesis was examined. This showed that only repair augmented with a DBM 1 MSCs reached a total bone mineral density not significantly lower than nonoperated controls, although the absolute values were similar to the other experimental groups. This may be because of the upper range of the data set skewing the statistical analysis, and we speculate that this difference would become more apparent with a larger sample size. Furthermore, this was not noted in a previous study in which a DBM was applied to a chronic rotator cuff tear model without MSCs. 41 We postulate that this may be caused by endogenous growth factors within a DBM (eg, BMPs), causing MSCs to differentiate into osteoblasts and subsequently to new bone formation by activating SMAD proteins and increasing the expression of Runt-related transcription factor 2 (RUNX2). 23 A low bone mineral density has been identified as an independent risk factor for postoperative rotator cuff healing, and thus, it is plausible that the small improvement demonstrated in this study may improve tendon healing in vivo through its effect on increasing the pullout strength of suture anchors. However, this does need to be investigated more comprehensively to determine whether this difference is maintained at later time points (to withstand the high forces exerted on the repair construct during rehabilitation) and to define the precise cellular mechanism responsible for it. 9, 45 To determine whether MSCs could enhance the structure of the healing enthesis compared with repairs without MSCs, the results of this experiment were compared with a previously published study that utilized the same animal model and scaffolds. 41 It was hypothesized that the addition of MSCs would yield a morphologically superior interface. This was partially supported by the results in that groups treated with MSCs alone and a DBM 1 MSCs had a more mature enthesis (characterized by a significantly higher enthesis maturation score) than those repaired with a dermal matrix. The addition of MSCs to a dermal matrix produced a tendon that was significantly less degenerative (characterized by a lower modified Movin score). Furthermore, repairs with MSCs alone produced a tendon that was significantly less degenerative than nonaugmented controls and repairs enhanced with a dermal matrix. This highlights a supplementary role of MSCs in enthesis healing when used in conjunction with biological scaffolds.
Several in vivo studies have evaluated the use of MSCs in tendon-bone healing. [17] [18] [19] [20] In a severe model of acute tendon retraction, Thangarajah et al 42 applied a DBM incorporated with MSCs (derived from the mononuclear fraction of a bone marrow aspirate) to the healing enthesis. At 12 weeks, there was reconstitution of the tendon-bone interface with a predominance of mineralized fibrocartilage and an improvement in functional weightbearing. In a nondegenerative rotator cuff tear model, Gulotta et al 17 applied MSCs to an acutely detached supraspinatus tendon. At 4 weeks, the biomechanical strengths of the repairs were equal between the MSC and control groups, and there was no difference in the amount of new cartilage formation or collagen fiber organization. This was attributed to a lack of growth/transcription factors, and thus, further studies evaluated the effect of membrane type 1 matrix metalloproteinase (MT1-MMP) on MSCs and MSCs transduced with adenoviral-mediated scleraxis. 18, 19 The results suggested that MSCs used in this context could result in more fibrocartilage, a higher ultimate load to failure, and a higher ultimate stress to failure.
The current study could not reproduce the results of MSC-induced tendon-bone healing observed in other animal models, even in the presence of a DBM. 18, 19, 42 This is most likely because of the limited tendon-bone surface area in a rat model not presenting an environment that is as conducive to healing as large animal models and those that utilize a tendon-bone tunnel. 15, 17 A DBM contains multiple growth factors such as BMPs and transforming growth factors. 35, 36, [47] [48] [49] We speculate that these were Figure 13 . Box and whisker plot showing total bone mineral density at the supraspinatus tendon-bone insertion 6 weeks after repair with and without mesenchymal stem cells (MSCs). DBM, demineralized bone matrix.
released slowly over time and were therefore unable to completely exert their effect on the MSCs during the 6 weeks in which enthesis healing was permitted to take place. The limitations of this study are principally the short time period (6 weeks) over which the healing enthesis was allowed to develop. It is feasible that with a longer study protocol, the new bony ingrowth in the DBM group that led to a preservation of bone mineral density compared with the other experimental groups in which the bone mineral density had decreased could have developed into fibrocartilage and mineralized fibrocartilage. A larger number of animals within the groups may have resulted in more significant values and a clearer indication of the benefits or drawbacks of the treatments. The lack of biomechanical testing precludes a discussion about functional recovery of the enthesis, which is a particularly important consideration in the clinical setting, as this may affect the type and success of postoperative rehabilitation after rotator cuff repair.
CONCLUSION
In conclusion, this study demonstrated that when a DBM and MSCs were applied to the healing enthesis in a chronic rotator cuff tear model, a fibrocartilaginous-based structure was produced, albeit not significantly more mature than the other experimental groups. Aside from these important histological findings, pqCT analysis showed that it was only in the DBM 1 MSC specimens where the bone mineral density was not significantly different from nonoperated controls.
